These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4807077)

  • 1. [Changes of the electrophoretic tracing of the serum glycoproteins in arteriosclerotic patients treated with clofibrate].
    Notarbartolo A; Rini GB; Campisi D
    Boll Soc Ital Cardiol; 1973; 18(4):373-8. PubMed ID: 4807077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
    Cajozzo A; Abbadessa V; Carreca I; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of clofibrate on serum lipid pattern in patients with arteriosclerosis].
    Markiewicz K; Walasek L; Pelka W; Lutz W
    Pol Tyg Lek; 1973 Jul; 28(30):1144-7. PubMed ID: 4732710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of the humoral lipid picture in arteriosclerotis subjects treated with clofibrate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):384-94. PubMed ID: 4807079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of electrocardiographic and rheographic tracings in atherosclerotic subjects treated with clofibrate].
    Furitano G; Aguglia V
    Boll Soc Ital Cardiol; 1973; 18(4):357-60. PubMed ID: 4807074
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy].
    Parenti M; Pasquali R; Bianchi V; Barillari C; Vezzadini P
    Minerva Med; 1979 Feb; 70(8):587-93. PubMed ID: 431877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients].
    Passowicz L
    Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electrophoretic study of serum glycoproteins in patients with atherosclerosis].
    Grigorian DG; Studnitsyna LA; Lysenko VB
    Ter Arkh; 1967 Jun; 39(6):50-2. PubMed ID: 5600685
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet stickiness and serum cholesterol levels after myocardial infarction treated with clofibrate and heparine.
    Kusá O
    Acta Univ Carol Med Monogr; 1972; 53():413-6. PubMed ID: 4670747
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary studies on changes induced by clofibrate in the values of haptoglobin and orosomucoid in arteriosclerotic subjects].
    Cajozzo A; Citarrella P; Malleo C; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):368-72. PubMed ID: 4807076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of hepatic function before and after administration of therapeutic doses of clofibrate].
    Dal Monte PR; Menghi B; Cremonini R; Sarti F; Toscano S
    Minerva Med; 1971 Dec; 62(97):4815-29. PubMed ID: 5131188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of long-term administration of clofibrate on the composition of blood lipids in atherosclerotic patients].
    Poleszak J; Korolko A
    Pol Tyg Lek; 1971 Jul; 26(29):1106-9. PubMed ID: 5098907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.